Results

Total Results: 2,224 records

Showing results for "medication".
Users also searched for: medication reconciliation

81. Recommendation: Breast Cancer: Medication Use to Reduce Risk | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-medications-for-risk-reduction
    September 03, 2019 - to Email Print Final Recommendation Statement Breast Cancer: Medication … Update in Progress for Breast Cancer: Medication to Reduce Risk … aromatase inhibitors, to women who are at increased risk for breast cancer and at low risk for adverse medication … Medication Use for the Risk Reduction of Primary Breast Cancer in Women: A Systematic Review for the … Medication use for the risk reduction of primary breast cancer in women: updated evidence report and

82. A and B Recommendations | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation-topics/uspstf-and-b-recommendations
    December 01, 2021 - 2016 * Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication … risk for preeclampsia The USPSTF recommends the use of low-dose aspirin (81 mg/day) as preventive medication … B August 2019 * Breast Cancer: Medication Use to Reduce Risk: women at increased risk … B April 2018 * Folic Acid for the Prevention of Neural Tube Defects: Preventive Medication … : newborns The USPSTF recommends prophylactic ocular topical medication for all newborns to prevent

83. Medication Use to Reduce Risk of Breast Cancer: US Preventive Services Task Force Recommendation Statement (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/3Kwu7j_WfCFQSnSzqrDWwt
    June 20, 2019 - Medication Use to Reduce Risk of Breast Cancer: US Preventive Services Task Force Recommendation Statement … Medication Use to Reduce Risk of Breast Cancer US Preventive Services Task Force Recommendation Statement … Clinical Review & Education US Preventive Services Task Force USPSTF Recommendation: Medication Use to … Clinical Summary: Medication Use to Reduce Risk of Breast Cancer Population Recommendation Women … Based on limited survey data, 10% to 30% (depending on medication type) of pri- mary care clinicians

84. Draft Evidence Review: Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/draft-evidence-review/vitamin-supplementation-to-prevent-cvd-and-cancer-preventive-medication
    May 04, 2021 - Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication

85. Draft Research Plan: Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/vitamin-supplementation-to-prevent-cvd-and-cancer-preventive-medication
    May 23, 2019 - Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication

86. Final Evidence Review: Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review/vitamin-supplementation-to-prevent-cvd-and-cancer-preventive-medication
    June 21, 2022 - Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication

87. Final Research Plan: Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/vitamin-supplementation-to-prevent-cvd-and-cancer-preventive-medication
    September 05, 2019 - Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication

88. Archived: Final Research Plan: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan98/statin-use-in-adults-preventive-medication-november-2016
    May 02, 2014 - Research Plan Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication

89. A and B Recommendations | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation-topics/uspstf-a-and-b-recommendations
    January 01, 2025 - risk for preeclampsia The USPSTF recommends the use of low-dose aspirin (81 mg/day) as preventive medication … B August 2019 * Breast Cancer: Medication Use to Reduce Risk: women at increased risk … B June 2024 Folic Acid Supplementation to Prevent Neural Tube Defects: Preventive Medication … B March 2021 * Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum: Preventive Medication … : newborns The USPSTF recommends prophylactic ocular topical medication for all newborns to prevent

90. Evidence Summary: Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/vitamin-supplementation-to-prevent-cvd-and-cancer-preventive-medication
    June 21, 2022 - Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication … www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/vitamin-supplementation-to-prevent-cvd-and-cancer-preventive-medication

91. Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum: US Preventive Services Task Force Reaffirmation Recommendation Statement (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/hEp2uYfD9KRhYTY5fGr8Tp
    October 15, 2018 - Summary of Recommendation and Evidence The USPSTF recommends prophylactic ocular topical medication for … Benefits of Preventive Medication The USPSTF found convincing evidence that ocular prophylaxis of newborns … Harms of Preventive Medication The USPSTF found convincing evidence that ocular prophylaxis of newborns … Potential Harms of Preventive Medication The USPSTF found no new data that would change its previous … Possible harms include the potential for antimicrobial resistance to treatment medication.

92. Final Research Plan: Anxiety in Children and Adolescents: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/screening-anxiety-children-adolescents
    March 29, 2022 - disorder/dysthymia, disruptive mood dysregulation disorder, premenstrual dysphoric disorder, substance/medication-induced … CBT plus medication would be eligible]) KQs 1, 3:  No comparator KQ 2:  Another screening instrument … study) KQs 4, 5:  No comparator, active intervention (i.e., comparative effectiveness); for example, medication … X vs. medication Y would not be eligible, nor would CBT plus medication X vs. … CBT plus medication Y KQ 4, 5 (anxiety and depression):  Treatment as usual comparator groups where

93. Final Research Plan: Depression and Suicide Risk in Children and Adolescents: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/screening-depression-suicide-risk-children-adolescents
    August 13, 2020 - disorder/dysthymia, disruptive mood dysregulation disorder, premenstrual dysphoric disorder, substance/medication-induced … CBT plus medication would be eligible]) KQs 1, 3: No comparator KQ 2: Another screening instrument … study) KQs 4, 5: No comparator, active intervention (i.e., comparative effectiveness); for example, medication … X vs. medication Y would not be eligible, nor would CBT plus medication X vs. … CBT plus medication Y KQ 4, 5 (anxiety and depression): Treatment as usual comparator groups where

94. U.S. Preventive Services Task Force Issues Final Recommendation Statement for Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/announcements/us-preventive-services-task-force-issues-final-recommendation-statement-ocular-prophylaxis-gonococcal-ophthalmia-neonatorum
    July 28, 2011 - Force (USPSTF) has reaffirmed its 2005 recommendation that all newborns should receive topical eye medication … available at /uspstf/recommendation/ocular-prophylaxis-for-gonococcal-ophthalmia-neonatorum-preventive-medication

95. Archived: Vitamin Supplementation to Prevent Cancer and CVD: Counseling and Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/vitamin-supplementation-to-prevent-cancer-and-cvd-counseling-and-preventive-medication-2003
    June 15, 2003 - Recommendation Statement Vitamin Supplementation to Prevent Cancer and CVD: Counseling and Preventive Medication … Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication … ) Recommendation Summary Population Recommendation Grade Preventive Medication … D Preventive Medication -- Vitamins A, C, E, Multivitamin with Folic Acid The USPSTF concludes … final-evidence-summary53/vitamin-supplementation-to-prevent-cancer-and-cvd-counseling-and-preventive-medication

96. Archived: Evidence Summary: Screening for Dyslipidemia in Younger Adults: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-dyslipidemia/statin-use-in-adults-preventive-medication-november-2016
    November 13, 2016 - Younger Adults Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication

97. Archived: Evidence Summary: Statins for Prevention of Cardiovascular Disease in Adults: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-statins/statin-use-in-adults-preventive-medication-november-2016
    November 13, 2016 - Disease in Adults Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication … recommendation statement: statin use for the primary prevention of cardiovascular disease in adults: preventive medication … HbA1c <12% SBP <200 mm Hg DBP <110 mm Hg Not receiving any other lipid-lowering medication … and 15 to 300 mg/24 h in two 24-h samples) Blood pressure <160/100 mm Hg and no antihypertensive medication … TC <309 mg/dL or <193 mg/dL if previous MI No lipid lowering medication 4 y Moderate

98. Archived: Evidence Summary: Aspirin for the Prevention of Cardiovascular Disease: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary10/aspirin-for-the-prevention-of-cardiovascular-disease-preventive-medication-2009
    March 15, 2009 - archived Evidence Summary Aspirin for the Prevention of Cardiovascular Disease: Preventive Medication … by the end of the trial: 28% of diabetic patients in the aspirin group had discontinued use of the medication

99. Final Research Plan: Falls Prevention in Community-Dwelling Older Adults: Interventions | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/falls-prevention-community-dwelling-older-adults-interventions
    July 21, 2022 - Exercise (supervised or unsupervised, individual or group) Multifactorial assessment and intervention Medication … The intervention name “medication management” was also changed to “medication modification/review” to

100. Aspirin Use for the Prevention of Morbidity and Mortality From Preeclampsia (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/8mY8Vp8f2BntTAbxwX7mYk
     March 22, 2021 - available over the counter, but pregnant people should talk to their healthcare provider before taking the medication … It is based on the quality and strength of the evidence about the potential benefits and harms of medication … When the Task Force issues a B Grade, it recommends the use of a preventive medication because it has … Mortality From Preeclampsia 1 The USPSTF recommends the use of low-dose aspirin (81 mg/d) as preventive medication